The $1 million from the 2023 Innovators Challenge will allow SAIL to expand its development of new single-cell analytic tools and more broadly implement existing methods, including multiplexed imaging, to advance rare cancer research across several MSK labs. This funding will help SAIL propel rare cancer research at MSK and accelerate the development of new and more effective treatments.